Corrigendum to "Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways" [Int. Immunopharmacol. 55 (2018) 9-19]
- PMID: 38040552
- DOI: 10.1016/j.intimp.2023.111252
Corrigendum to "Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways" [Int. Immunopharmacol. 55 (2018) 9-19]
Erratum for
-
Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways.Int Immunopharmacol. 2018 Feb;55:9-19. doi: 10.1016/j.intimp.2017.11.040. Epub 2017 Dec 5. Int Immunopharmacol. 2018. PMID: 29207360
Publication types
LinkOut - more resources
Full Text Sources